Overview
Locked-in syndrome (LIS), also known as cerebromedullospinal disconnection, pseudocoma, or de-efferented state, is a rare and devastating neurological condition characterized by complete paralysis of nearly all voluntary muscles in the body while consciousness and cognitive function remain fully intact. The condition results from damage to the ventral portion of the pons (a part of the brainstem), most commonly caused by a basilar artery thrombosis or hemorrhagic stroke. Other causes include traumatic brain injury, brainstem tumors, central pontine myelinolysis, infections, or demyelinating diseases. Patients are typically quadriplegic and unable to speak, swallow, or produce facial movements, but retain the ability to move their eyes vertically and blink, which becomes their primary means of communication. The syndrome profoundly affects the motor nervous system while sparing consciousness, cognition, and sensation. Patients are fully aware of their surroundings but are unable to move or communicate except through vertical eye movements and blinking. Three forms are recognized: classical (quadriplegia and anarthria with preserved vertical eye movements and blinking), incomplete (remnants of voluntary movement beyond eye movements are preserved), and total (complete immobility including all eye movements, with preserved consciousness detectable only by electroencephalography or functional neuroimaging). Respiratory function is often compromised, and many patients require mechanical ventilation, particularly in the acute phase. There is currently no cure for locked-in syndrome, and treatment is primarily supportive. Acute management focuses on maintaining airway patency, respiratory support, nutritional support via gastrostomy, prevention of complications such as deep vein thrombosis, pressure ulcers, and infections, and early rehabilitation. Communication aids, including eye-tracking devices and brain-computer interfaces, have significantly improved quality of life for some patients. Physical therapy and occupational therapy are essential components of long-term care. Prognosis varies depending on the underlying cause; some patients with incomplete forms may recover limited motor function, though full recovery is exceedingly rare. Long-term survival is possible with appropriate medical care, and studies have shown that many chronic locked-in patients report an acceptable quality of life.
Also known as:
Clinical phenotype terms— hover any for plain English:
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
5 eventsVA Office of Research and Development — NA
Amy Wagner — NA
Sean Devitt — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Locked-in syndrome.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Locked-in syndrome.
Community
No community posts yet. Be the first to share your experience with Locked-in syndrome.
Start the conversation →Latest news about Locked-in syndrome
Disease timeline:
New recruiting trial: Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
A new clinical trial is recruiting patients for Locked-in syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Locked-in syndrome
What is Locked-in syndrome?
Locked-in syndrome (LIS), also known as cerebromedullospinal disconnection, pseudocoma, or de-efferented state, is a rare and devastating neurological condition characterized by complete paralysis of nearly all voluntary muscles in the body while consciousness and cognitive function remain fully intact. The condition results from damage to the ventral portion of the pons (a part of the brainstem), most commonly caused by a basilar artery thrombosis or hemorrhagic stroke. Other causes include traumatic brain injury, brainstem tumors, central pontine myelinolysis, infections, or demyelinating di
At what age does Locked-in syndrome typically begin?
Typical onset of Locked-in syndrome is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Locked-in syndrome?
Yes — 1 recruiting clinical trial is currently listed for Locked-in syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Locked-in syndrome?
25 specialists and care centers treating Locked-in syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.